| Financial Year |
March 31 2023 |
| Monetary Funds |
159,165,461.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
200,000.00 |
| Accounts Receivable |
118,611,609.84 |
| Advances to Suppliers |
5,008,596.87 |
| Other Receivables |
7,394,409.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
48,432,619.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,297,085.66 |
| Total Current Assets |
373,778,048.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,278,585.20 |
| Investment Properties |
-- |
| Fixed Assetes |
154,258,434.47 |
| Under-construction Projects |
266,492,612.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,402,315.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
5,482,870.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
466,214,817.75 |
| Total Assets |
839,992,865.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
29,824,216.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,266,974.20 |
| Taxes Payable |
2,227,754.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,965,574.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
280.19 |
| Sub-Total of Current Liabilities |
82,519,277.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,129,431.90 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,851,067.05 |
| Total Liabilities |
105,370,344.12 |
| Paid-In Capital(Or Share Stock) |
66,680,000.00 |
| Capital Surplus |
220,710,452.33 |
| Surplus Reserve |
35,500,180.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
407,601,812.49 |
| Minority Stockholder's Interest |
4,130,076.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
730,492,445.33 |
| Owner's Equity（Stockholder's Equity） |
734,622,521.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
839,992,865.77 |
